Ketamine
|
group of stereoisomers (en) | |
| Bayanai | |
| Ƙaramin ɓangare na |
chemical compound (en) |
| Bangare na |
response to ketamine (en) |
| Amfani | magani |
| Karatun ta |
ketamine in depression (en) |
| Sinadaran dabara | C₁₃H₁₆ClNO |
| Canonical SMILES (en) | CNC1(CCCCC1=O)C2=CC=CC=C2Cl |
| World Health Organisation international non-proprietary name (en) | ketamine |
| Medical condition treated (en) |
pain (en) |
| Pregnancy category (en) |
Australian pregnancy category B3 (en) |
| LiverTox likelihood score (en) |
LiverTox toxicity likelihood category B (en) |
| By-product (en) |
CanKet (en) |
Ketamine magani ne wanda aka fi amfani dashi don farawa da kiyaye anesthesia.[1] Yana haifar da yanayi mai kama da hankali yayin da yake ba da taimako na jin zafi, kwantar da hankali, da asarar ƙwaƙwalwar ajiya . [2] Sauran amfani sun haɗa da kwantar da hankali a cikin kulawa mai zurfi da maganin ciwo da damuwa . [3] [4] [5] [6] Ayyukan zuciya, numfashi, da motsin iska gabaɗaya sun kasance masu aiki. [2] Yawanci yana farawa a cikin mintuna biyar lokacin da aka yi masa allura, kuma yana ɗaukar kusan mintuna 25. [1] [7]
Abubuwan illa na yau da kullun sun haɗa da tashin hankali, ruɗani, ko hasashe yayin da magani ya ƙare. Hawan jini da girgizar tsoka suna da yawa. Spasms na makogwaro na iya faruwa da wuya. Ketamine mai karɓar NMDA ne, amma yana iya samun wasu ayyuka.
An gano Ketamine a cikin 1962, an fara gwada shi a cikin mutane a cikin 1964, kuma an amince da shi don amfani a Amurka a cikin 1970. [7] [8] An yi amfani da shi sosai don maganin maganin tiyata a Yaƙin Vietnam saboda amincinsa. [8] Yana cikin Jerin Mahimman Magunguna na Hukumar Lafiya ta Duniya . [9] Ana samunsa azaman magani gamayya . [1] Farashin farashi a cikin ƙasashe masu tasowa tsakanin $ 0.84 da US $ 3.22 kowace vial. [10] Hakanan ana amfani da Ketamine azaman magani na nishaɗi don tasirin hallucinogenic da dissociative . [11]
Bayanan da aka ambata
[gyara sashe | gyara masomin]- ↑ 1.0 1.1 1.2 "Ketamine Injection". Drugs.com. Archived from the original on 10 December 2014. Retrieved 1 December 2014.
- ↑ 2.0 2.1 Green SM, Roback MG, Kennedy RM, Krauss B (May 2011). "Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update". Annals of Emergency Medicine. 57 (5): 449–61. doi:10.1016/j.annemergmed.2010.11.030. PMID 21256625.
- ↑ Zgaia AO, Irimie A, Sandesc D, Vlad C, Lisencu C, Rogobete A, Achimas-Cadariu P (2015). "The role of ketamine in the treatment of chronic cancer pain". Clujul Medical. 88 (4): 457–61. doi:10.15386/cjmed-500. PMC 4689236. PMID 26733743.
- ↑ Zapantis A, Leung S (September 2005). "Tolerance and withdrawal issues with sedation". Critical Care Nursing Clinics of North America. 17 (3): 211–23. doi:10.1016/j.ccell.2005.04.011. PMID 16115529.
- ↑ Zhang K, Hashimoto K (January 2019).
- ↑ Kraus C, Rabl U, Vanicek T, Carlberg L, Popovic A, Spies M, et al. (March 2017). "Administration of ketamine for unipolar and bipolar depression". International Journal of Psychiatry in Clinical Practice. 21 (1): 2–12. doi:10.1080/13651501.2016.1254802. PMID 28097909.
- ↑ 7.0 7.1 "Ketamine – CESAR". Center for Substance Abuse Research. University of Maryland. Archived from the original on 12 November 2013. Retrieved 26 September 2014.
- ↑ 8.0 8.1 Domino EF (September 2010). "Taming the ketamine tiger. 1965". Anesthesiology. 113 (3): 678–84. doi:10.1097/ALN.0b013e3181ed09a2. PMID 20693870. Archived (PDF) from the original on 28 August 2021. Retrieved 9 August 2020.
- ↑ Empty citation (help)
- ↑ "Ketamine". Archived from the original on 23 August 2017. Retrieved 12 January 2016.
- ↑ Morgan CJ, Curran HV (January 2012). "Ketamine use: a review". Addiction. 107 (1): 27–38. doi:10.1111/j.1360-0443.2011.03576.x. PMID 21777321. Archived from the original on 28 August 2021. Retrieved 9 August 2020.